Thesis (M.A.) -- Central Connecticut State University, 2009. / Thesis advisor: Joanne DiPlacido. "... in partial fulfillment of the requirements for the degree of Master of Arts in Psychology." Includes bibliographical references (leaves 103-114). Also available via the World Wide Web.

Thesis (M.S.)--Virginia Polytechnic Institute and State University, 1988. / Vita. Abstract. Includes bibliographical references (leaves 60-62). Also available via the Internet.

Thesis (Ph. D.)--Drexel University, 2004. / Includes abstract and vita. Includes bibliographical references (leaves 138-148).

Thesis (M. P. H.)--University of Hong Kong, 2007. / Also available in print.

Thesis (Ph. D.)--New York University, 2001. / Includes bibliographical references (leaves 337-380).

Thesis (M.P.H.)--University of Hong Kong, 2007.

The Pharmaceutical Industry is important both socially and economically; however, the market structure and conduct which distinguishes it have brought it under the critical eye of both the regulatory authorities and the public. This thesis describes the market structure and conduct of the industry beginning with an historical description of its development and the market theories behind it. It is from these theories that a number of characteristics and behavioural traits have been identified as contrary to the interests of society. As an oligopolistic multinational the pharmaceutical industry has been identified with high prices and profits, a lack of price competition and heavy product differentiation leading to high concentration ratios. Consumer exploitation is possible via these continuously high prices and the possibilities of ineffective, unsafe and poor quality pharmaceuticals. These outcomes emerge from the distinct organisation of various aspects of the industry, viz. research and development, promotional activities, pricing and profits, which are examined. Concerns over possible consumer exploitation have led governments throughout the world to impose increasingly stringent regulations on all of these aspects. Such regulations have significantly changed the market structure and conduct of the industry world-wide. Having established the market structure of the industry the thesis continues with an in-depth look at brand loyalty. Analysis was conducted on the strength of brand loyalty in the face of generic competition and the attitude of doctors to company promotional material. While brand loyalty continues to have an impact on prescribing its strength appears to be diminishing. The market structure and conduct of the pharmaceutical industry is dynamic, with the present industrial climate increasingly competitive for all those concerned. Nevertheless, while the future of the industry will be difficult, evidence of its previous flexibility and strength suggests it will adapt and will continue to be successful.

Thesis (Ph. D.)--University of Wisconsin--Madison, 1972. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (Ph. D.)--University of Wisconsin--Madison, 1970. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (M.S.)--State University of New York at Binghamton, Thomas J. Watson School of Engineering and Applied Science, Department of Systems Science and Industrial Engineering, 2008. / Includes bibliographical references.